Background: Cleft palate is a congenital disability affecting the palate’s structure and function, which may lead to delayed speech and language development and communication disorders. There is a shortage of speech therapists in Thailand. Therefore, developing a manual for speech and language treatment for the parents of children with a cleft palate would be an essential early intervention that parents could perform. Objectives: This research aimed to develop a speech and language treatment manual for parents of children with cleft palate ages 0-3 years old and evaluate the manual’s effectiveness, satisfaction, and feedback. Materials and methods: This research was divided into Phase 1, which involved developing a speech and language treatment manual for parents of children with cleft palate ages 0-3 years old and assessing its validity and reliability. Phase 2 tested the manual’s effectiveness by conducting a three-month of 16 participants, who were divided into two groups: A control group without the manual and an experimental group with the manual and phase 3 data analysis. Results: The content validity of the manual and satisfaction of the questionnaires were found to have a content validity index of 0.87 and 0.92, respectively. The total language and speech development scores before and after participating between groups found a statistically significant difference. After participating, the number of the experimental group who passed the 90th percentile of language development was higher than the control group. The language between the children and parents showed that the experimental group displayed more communication skills than the control group. Conclusion: The speech and language treatment manual for parents of children with cleft palate ages 0-3 years old could stimulate the language and speech development of the experimental group more effectively than the control group that did not receive the manual.
{"title":"The Development of manual for speech and language treatment for parents of children with cleft palate ages 0-3 years old","authors":"Pechcharat Jaiyong, Phuanjai Rattakorn, Supaporn Chinchai","doi":"10.12982/jams.2024.007","DOIUrl":"https://doi.org/10.12982/jams.2024.007","url":null,"abstract":"Background: Cleft palate is a congenital disability affecting the palate’s structure and function, which may lead to delayed speech and language development and communication disorders. There is a shortage of speech therapists in Thailand. Therefore, developing a manual for speech and language treatment for the parents of children with a cleft palate would be an essential early intervention that parents could perform. Objectives: This research aimed to develop a speech and language treatment manual for parents of children with cleft palate ages 0-3 years old and evaluate the manual’s effectiveness, satisfaction, and feedback. Materials and methods: This research was divided into Phase 1, which involved developing a speech and language treatment manual for parents of children with cleft palate ages 0-3 years old and assessing its validity and reliability. Phase 2 tested the manual’s effectiveness by conducting a three-month of 16 participants, who were divided into two groups: A control group without the manual and an experimental group with the manual and phase 3 data analysis. Results: The content validity of the manual and satisfaction of the questionnaires were found to have a content validity index of 0.87 and 0.92, respectively. The total language and speech development scores before and after participating between groups found a statistically significant difference. After participating, the number of the experimental group who passed the 90th percentile of language development was higher than the control group. The language between the children and parents showed that the experimental group displayed more communication skills than the control group. Conclusion: The speech and language treatment manual for parents of children with cleft palate ages 0-3 years old could stimulate the language and speech development of the experimental group more effectively than the control group that did not receive the manual.","PeriodicalId":298884,"journal":{"name":"Journal of Associated Medical Sciences","volume":"50 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139124404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Cleft palate is a congenital disability affecting the palate’s structure and function, which may lead to delayed speech and language development and communication disorders. There is a shortage of speech therapists in Thailand. Therefore, developing a manual for speech and language treatment for the parents of children with a cleft palate would be an essential early intervention that parents could perform. Objectives: This research aimed to develop a speech and language treatment manual for parents of children with cleft palate ages 0-3 years old and evaluate the manual’s effectiveness, satisfaction, and feedback. Materials and methods: This research was divided into Phase 1, which involved developing a speech and language treatment manual for parents of children with cleft palate ages 0-3 years old and assessing its validity and reliability. Phase 2 tested the manual’s effectiveness by conducting a three-month of 16 participants, who were divided into two groups: A control group without the manual and an experimental group with the manual and phase 3 data analysis. Results: The content validity of the manual and satisfaction of the questionnaires were found to have a content validity index of 0.87 and 0.92, respectively. The total language and speech development scores before and after participating between groups found a statistically significant difference. After participating, the number of the experimental group who passed the 90th percentile of language development was higher than the control group. The language between the children and parents showed that the experimental group displayed more communication skills than the control group. Conclusion: The speech and language treatment manual for parents of children with cleft palate ages 0-3 years old could stimulate the language and speech development of the experimental group more effectively than the control group that did not receive the manual.
{"title":"The Development of manual for speech and language treatment for parents of children with cleft palate ages 0-3 years old","authors":"Pechcharat Jaiyong, Phuanjai Rattakorn, Supaporn Chinchai","doi":"10.12982/jams.2024.007","DOIUrl":"https://doi.org/10.12982/jams.2024.007","url":null,"abstract":"Background: Cleft palate is a congenital disability affecting the palate’s structure and function, which may lead to delayed speech and language development and communication disorders. There is a shortage of speech therapists in Thailand. Therefore, developing a manual for speech and language treatment for the parents of children with a cleft palate would be an essential early intervention that parents could perform. Objectives: This research aimed to develop a speech and language treatment manual for parents of children with cleft palate ages 0-3 years old and evaluate the manual’s effectiveness, satisfaction, and feedback. Materials and methods: This research was divided into Phase 1, which involved developing a speech and language treatment manual for parents of children with cleft palate ages 0-3 years old and assessing its validity and reliability. Phase 2 tested the manual’s effectiveness by conducting a three-month of 16 participants, who were divided into two groups: A control group without the manual and an experimental group with the manual and phase 3 data analysis. Results: The content validity of the manual and satisfaction of the questionnaires were found to have a content validity index of 0.87 and 0.92, respectively. The total language and speech development scores before and after participating between groups found a statistically significant difference. After participating, the number of the experimental group who passed the 90th percentile of language development was higher than the control group. The language between the children and parents showed that the experimental group displayed more communication skills than the control group. Conclusion: The speech and language treatment manual for parents of children with cleft palate ages 0-3 years old could stimulate the language and speech development of the experimental group more effectively than the control group that did not receive the manual.","PeriodicalId":298884,"journal":{"name":"Journal of Associated Medical Sciences","volume":"50 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139124533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
T. Tatu, Wachirawit Tondee, Pornchai Khamtong, Lamplimas Tangphan, Jidapa Jaitiang
Background: Four university students of northern Thai descent were found to be HbE/βO-thalassemia. However, they all had a mild form of this disease, categorized as Non-Transfusion Dependent Thalassemia. Objectives: To analyze involvement of types of β-globin mutations, α-thalassemia, and XmnI-Gγ site in mild clinical symptoms observed in four Thai non-transfusion dependent HbE/βO-thalassemia cases. Materials and methods: EDTA blood samples were collected from the patients and their family members after signing the informed consent. Automated complete blood count with blood smear examination, hemoglobin typing, molecular analysis for α and β-globin mutations, β-globin gene haplotypes, and XmnI-Gγ site were performed on all blood samples. In addition, nucleotide sequencing of β-globin gene and globin chain separation were performed for patient#3 and their parents. Results: The first three patients had hemoglobin levels ranging 8.5-11.2 g/dL, while the fourth patient had hemoglobin level of 6.7 g/dL. The first and fourth patients were compound heterozygote for βE (HBB:c.79G>A) and β17 (HBB:c.52A>T) alleles with typical hemoglobin pattern of EF. The second patient was compound heterozygote for βE and β41/42 (HBB:c.126_129delCTTT) alleles also with typical hemoglobin pattern of EF. The third patient was compound heterozygote of βE and βIVS1-1(HBB:c.92+1G>T), however, with atypical hemoglobin pattern of EE. Family analysis found co-inheritance of Hb Constant Spring (HBA2:c.427T>C) and the XmnI-Gγ site (T at rs7482144) in the first two patients, of SEA-αO thalassemia (NG_000006.1:g.26264_45564del19301) and XmnI-Gγ site in the third patient, and of only XmnI-Gγ site in the fourth patient. Conclusion: These family studies proved the fact that co-existence of SEA-αO thalassemia and Hb Constant Spring in HbE/βO-thalassemia could lead to mild clinical severity. Minimal effect of XmnI-Gγ site on clinical symptoms of this disease was emphasized. This information should be useful in prenatal diagnosis of HbE/β-thalassemia.
{"title":"Non-transfusion dependent HbE/βO-thalassemia as the results of co-existent SEA-αO thalassemia, Hb Constant Spring, and XmnI-Gγ site: Thai family studies","authors":"T. Tatu, Wachirawit Tondee, Pornchai Khamtong, Lamplimas Tangphan, Jidapa Jaitiang","doi":"10.12982/jams.2024.006","DOIUrl":"https://doi.org/10.12982/jams.2024.006","url":null,"abstract":"Background: Four university students of northern Thai descent were found to be HbE/βO-thalassemia. However, they all had a mild form of this disease, categorized as Non-Transfusion Dependent Thalassemia. Objectives: To analyze involvement of types of β-globin mutations, α-thalassemia, and XmnI-Gγ site in mild clinical symptoms observed in four Thai non-transfusion dependent HbE/βO-thalassemia cases. Materials and methods: EDTA blood samples were collected from the patients and their family members after signing the informed consent. Automated complete blood count with blood smear examination, hemoglobin typing, molecular analysis for α and β-globin mutations, β-globin gene haplotypes, and XmnI-Gγ site were performed on all blood samples. In addition, nucleotide sequencing of β-globin gene and globin chain separation were performed for patient#3 and their parents. Results: The first three patients had hemoglobin levels ranging 8.5-11.2 g/dL, while the fourth patient had hemoglobin level of 6.7 g/dL. The first and fourth patients were compound heterozygote for βE (HBB:c.79G>A) and β17 (HBB:c.52A>T) alleles with typical hemoglobin pattern of EF. The second patient was compound heterozygote for βE and β41/42 (HBB:c.126_129delCTTT) alleles also with typical hemoglobin pattern of EF. The third patient was compound heterozygote of βE and βIVS1-1(HBB:c.92+1G>T), however, with atypical hemoglobin pattern of EE. Family analysis found co-inheritance of Hb Constant Spring (HBA2:c.427T>C) and the XmnI-Gγ site (T at rs7482144) in the first two patients, of SEA-αO thalassemia (NG_000006.1:g.26264_45564del19301) and XmnI-Gγ site in the third patient, and of only XmnI-Gγ site in the fourth patient. Conclusion: These family studies proved the fact that co-existence of SEA-αO thalassemia and Hb Constant Spring in HbE/βO-thalassemia could lead to mild clinical severity. Minimal effect of XmnI-Gγ site on clinical symptoms of this disease was emphasized. This information should be useful in prenatal diagnosis of HbE/β-thalassemia.","PeriodicalId":298884,"journal":{"name":"Journal of Associated Medical Sciences","volume":"50 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139120955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Cleft palate is a congenital disability affecting the palate’s structure and function, which may lead to delayed speech and language development and communication disorders. There is a shortage of speech therapists in Thailand. Therefore, developing a manual for speech and language treatment for the parents of children with a cleft palate would be an essential early intervention that parents could perform. Objectives: This research aimed to develop a speech and language treatment manual for parents of children with cleft palate ages 0-3 years old and evaluate the manual’s effectiveness, satisfaction, and feedback. Materials and methods: This research was divided into Phase 1, which involved developing a speech and language treatment manual for parents of children with cleft palate ages 0-3 years old and assessing its validity and reliability. Phase 2 tested the manual’s effectiveness by conducting a three-month of 16 participants, who were divided into two groups: A control group without the manual and an experimental group with the manual and phase 3 data analysis. Results: The content validity of the manual and satisfaction of the questionnaires were found to have a content validity index of 0.87 and 0.92, respectively. The total language and speech development scores before and after participating between groups found a statistically significant difference. After participating, the number of the experimental group who passed the 90th percentile of language development was higher than the control group. The language between the children and parents showed that the experimental group displayed more communication skills than the control group. Conclusion: The speech and language treatment manual for parents of children with cleft palate ages 0-3 years old could stimulate the language and speech development of the experimental group more effectively than the control group that did not receive the manual.
{"title":"The Development of manual for speech and language treatment for parents of children with cleft palate ages 0-3 years old","authors":"Pechcharat Jaiyong, Phuanjai Rattakorn, Supaporn Chinchai","doi":"10.12982/jams.2024.007","DOIUrl":"https://doi.org/10.12982/jams.2024.007","url":null,"abstract":"Background: Cleft palate is a congenital disability affecting the palate’s structure and function, which may lead to delayed speech and language development and communication disorders. There is a shortage of speech therapists in Thailand. Therefore, developing a manual for speech and language treatment for the parents of children with a cleft palate would be an essential early intervention that parents could perform. Objectives: This research aimed to develop a speech and language treatment manual for parents of children with cleft palate ages 0-3 years old and evaluate the manual’s effectiveness, satisfaction, and feedback. Materials and methods: This research was divided into Phase 1, which involved developing a speech and language treatment manual for parents of children with cleft palate ages 0-3 years old and assessing its validity and reliability. Phase 2 tested the manual’s effectiveness by conducting a three-month of 16 participants, who were divided into two groups: A control group without the manual and an experimental group with the manual and phase 3 data analysis. Results: The content validity of the manual and satisfaction of the questionnaires were found to have a content validity index of 0.87 and 0.92, respectively. The total language and speech development scores before and after participating between groups found a statistically significant difference. After participating, the number of the experimental group who passed the 90th percentile of language development was higher than the control group. The language between the children and parents showed that the experimental group displayed more communication skills than the control group. Conclusion: The speech and language treatment manual for parents of children with cleft palate ages 0-3 years old could stimulate the language and speech development of the experimental group more effectively than the control group that did not receive the manual.","PeriodicalId":298884,"journal":{"name":"Journal of Associated Medical Sciences","volume":"50 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139121369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R. Cressey, Sudalak Sankunkit, Chonnipa Chaovatin, Natteewan Doungjinda, A. Lungkaphin
Background: Although atorvastatin is commonly used as a hypolipidemic agent, it confers many health benefits in which the underlying mechanisms are not fully understood. We have previously shown that combined treatment of atorvastatin and insulin effectively restored renal function of streptozotocin (STZ)-induced diabetic rats; nevertheless, the underlying mechanism was not known. Objective: To determine whether the reno-protective effect of atorvastatin and insulin is mediated through its impact on autophagy. Materials and methods: Markers of autophagy, LC3, and p62/SQSTM1, in rat kidney tissues and cell lines treated with atorvastatin and/or insulin were determined by Western blot analysis. Results: Levels of both LC3-I and LC3-II proteins in kidney tissues of STZ-diabetic rats treated with atorvastatin and insulin were significantly increased. The autophagic flux was examined in vitro and showed that high glucose culture conditions suppressed the autophagic flux in kidney cells. Treatment with insulin moderately increased the conversion of LC3-I to LC3-II. Interestingly, atorvastatin increased autophagic flux only in the hyperglycemic but not in the normoglycemic condition. p62/SQSTM1 protein level was decreased in response to high glucose treatment but increased with the addition of insulin and/or atorvastatin. Conclusion: This study has demonstrated that atorvastatin may represent a novel regimen in providing prevention and protection for diabetic nephropathy through the underlying mechanisms of inducing autophagy and p62/SQSTM1.
{"title":"Atorvastatin increases autophagic flux and p62/SQSTM1 of kidney cells in hyperglycemic conditions and treatment in combination with insulin improves renal function of streptozotocin (STZ)-induced diabetic rats","authors":"R. Cressey, Sudalak Sankunkit, Chonnipa Chaovatin, Natteewan Doungjinda, A. Lungkaphin","doi":"10.12982/jams.2024.016","DOIUrl":"https://doi.org/10.12982/jams.2024.016","url":null,"abstract":"Background: Although atorvastatin is commonly used as a hypolipidemic agent, it confers many health benefits in which the underlying mechanisms are not fully understood. We have previously shown that combined treatment of atorvastatin and insulin effectively restored renal function of streptozotocin (STZ)-induced diabetic rats; nevertheless, the underlying mechanism was not known. Objective: To determine whether the reno-protective effect of atorvastatin and insulin is mediated through its impact on autophagy. Materials and methods: Markers of autophagy, LC3, and p62/SQSTM1, in rat kidney tissues and cell lines treated with atorvastatin and/or insulin were determined by Western blot analysis. Results: Levels of both LC3-I and LC3-II proteins in kidney tissues of STZ-diabetic rats treated with atorvastatin and insulin were significantly increased. The autophagic flux was examined in vitro and showed that high glucose culture conditions suppressed the autophagic flux in kidney cells. Treatment with insulin moderately increased the conversion of LC3-I to LC3-II. Interestingly, atorvastatin increased autophagic flux only in the hyperglycemic but not in the normoglycemic condition. p62/SQSTM1 protein level was decreased in response to high glucose treatment but increased with the addition of insulin and/or atorvastatin. Conclusion: This study has demonstrated that atorvastatin may represent a novel regimen in providing prevention and protection for diabetic nephropathy through the underlying mechanisms of inducing autophagy and p62/SQSTM1.","PeriodicalId":298884,"journal":{"name":"Journal of Associated Medical Sciences","volume":"54 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139112448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Pootong, Priyoth Kittiteerasack, Parichart Pattarapanitchai, Sirinart Choomean
Background: Dyslipidemia is regarded as a significant risk factor for atherosclerotic cardiovascular diseases (ASCVDs). Currently, there is limited data regarding dyslipidemia among Thai university students. Objective: This study aimed to examine the prevalence of dyslipidemia and its related factors among university students in the central region of Thailand. Materials and methods: In this cross-sectional study, a total of 434 students aged 18-25 years at Thammasat University and Kasetsart University were recruited using simple random sampling. Fasting venous blood samples were obtained, and plasma lipid profiles were assessed by an automated analyzer. Dyslipidemia was formally characterized according to the National Cholesterol Education Program Adult Treatment Panel (NCEP-ATP III) guidelines. Demographic information, dietary behavior, and physical activity were collected using questionnaires. Anthropometric measures were also performed according to a standard protocol. Results: The prevalence of elevated total cholesterol, high-risk HDL-C, elevated LDL-C, and elevated triglycerides was 30.4, 18.2, 20.0, and 11.8%, respectively. The most common adverse lipid parameter was total cholesterol in both genders. Obesity and high fat intake were significantly associated with dyslipidemia (p<0.05). Conclusion: This research revealed a significant occurrence of dyslipidemia, primarily driven by elevated total cholesterol, among university students in Thailand. Obesity and high fat intake are significant risk contributors to dyslipidemia. These findings emphasize the need for awareness, prevention, and management strategies targeting this population.
{"title":"Prevalence and associated factors of dyslipidemia among university students in Central Thailand: a cross-sectional study","authors":"A. Pootong, Priyoth Kittiteerasack, Parichart Pattarapanitchai, Sirinart Choomean","doi":"10.12982/jams.2024.018","DOIUrl":"https://doi.org/10.12982/jams.2024.018","url":null,"abstract":"Background: Dyslipidemia is regarded as a significant risk factor for atherosclerotic cardiovascular diseases (ASCVDs). Currently, there is limited data regarding dyslipidemia among Thai university students. Objective: This study aimed to examine the prevalence of dyslipidemia and its related factors among university students in the central region of Thailand. Materials and methods: In this cross-sectional study, a total of 434 students aged 18-25 years at Thammasat University and Kasetsart University were recruited using simple random sampling. Fasting venous blood samples were obtained, and plasma lipid profiles were assessed by an automated analyzer. Dyslipidemia was formally characterized according to the National Cholesterol Education Program Adult Treatment Panel (NCEP-ATP III) guidelines. Demographic information, dietary behavior, and physical activity were collected using questionnaires. Anthropometric measures were also performed according to a standard protocol. Results: The prevalence of elevated total cholesterol, high-risk HDL-C, elevated LDL-C, and elevated triglycerides was 30.4, 18.2, 20.0, and 11.8%, respectively. The most common adverse lipid parameter was total cholesterol in both genders. Obesity and high fat intake were significantly associated with dyslipidemia (p<0.05). Conclusion: This research revealed a significant occurrence of dyslipidemia, primarily driven by elevated total cholesterol, among university students in Thailand. Obesity and high fat intake are significant risk contributors to dyslipidemia. These findings emphasize the need for awareness, prevention, and management strategies targeting this population.","PeriodicalId":298884,"journal":{"name":"Journal of Associated Medical Sciences","volume":"54 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139112567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Damayanti Sethy, Surjeet Sahoo, S. Sahoo, Kshanaprava Mohakud
Background: Rehabilitation of upper limb impairments and functional deficits is a top goal in stroke rehabilitation. Alternative therapeutic methods may be developed to facilitate upper limb recovery. Priming prepares the brain for better action. When some therapies accompany Priming, it results in a change in behaviour at the performance level by improving the effect of Neuro-Rehabilitation Therapies and enhancing change in the neural process. Objectives: To investigate the efficacy of movement-based priming combined with task-specific training on upper limb recovery in patients after stroke. Materials and methods: Twenty-four subjects in the early phase of stroke, attending the Department of Neurology in a tertiary care hospital of Bhubaneswar, Odisha participated in a single-blind randomized controlled trial. 24 subjects after stroke were recruited to the study and randomly allocated to a control group receiving task-specific training only (TST) and an experimental group receiving Movement-Based Priming with task-specific training (MBP+TST). The control group received only task-specific training for 45 minutes per session three days a week for six weeks, while the experimental group received 15 minutes of priming and 30 minutes of task-specific training. Fugl-Mayer Assessment of upper extremity (FMA-UE)was used to measure upper extremity motor recovery, and the Motor Activity Log (MAL) was used to measure the use of arm and hand during activities of daily living at baseline and after six weeks of therapy. Results: Both the TST group and the MBP+TST group had significantly improved their capacity to move and use their upper limbs functionally (p<0.001). FMA-UE and MAL scores improved more favorably in the MBP+TST group than in the TST group (p<0.001). Conclusion: Priming in combination with task-specific training results in better upper limb recovery than task-specific training alone.
{"title":"Effect of movement-based priming combined with task specific training on upper limb recovery in patients after stroke","authors":"Damayanti Sethy, Surjeet Sahoo, S. Sahoo, Kshanaprava Mohakud","doi":"10.12982/jams.2024.009","DOIUrl":"https://doi.org/10.12982/jams.2024.009","url":null,"abstract":"Background: Rehabilitation of upper limb impairments and functional deficits is a top goal in stroke rehabilitation. Alternative therapeutic methods may be developed to facilitate upper limb recovery. Priming prepares the brain for better action. When some therapies accompany Priming, it results in a change in behaviour at the performance level by improving the effect of Neuro-Rehabilitation Therapies and enhancing change in the neural process. Objectives: To investigate the efficacy of movement-based priming combined with task-specific training on upper limb recovery in patients after stroke. Materials and methods: Twenty-four subjects in the early phase of stroke, attending the Department of Neurology in a tertiary care hospital of Bhubaneswar, Odisha participated in a single-blind randomized controlled trial. 24 subjects after stroke were recruited to the study and randomly allocated to a control group receiving task-specific training only (TST) and an experimental group receiving Movement-Based Priming with task-specific training (MBP+TST). The control group received only task-specific training for 45 minutes per session three days a week for six weeks, while the experimental group received 15 minutes of priming and 30 minutes of task-specific training. Fugl-Mayer Assessment of upper extremity (FMA-UE)was used to measure upper extremity motor recovery, and the Motor Activity Log (MAL) was used to measure the use of arm and hand during activities of daily living at baseline and after six weeks of therapy. Results: Both the TST group and the MBP+TST group had significantly improved their capacity to move and use their upper limbs functionally (p<0.001). FMA-UE and MAL scores improved more favorably in the MBP+TST group than in the TST group (p<0.001). Conclusion: Priming in combination with task-specific training results in better upper limb recovery than task-specific training alone.","PeriodicalId":298884,"journal":{"name":"Journal of Associated Medical Sciences","volume":"53 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139112585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jureemas Wilaklang, Kalyanee Makarabhirom, S. Thayansin, Phurich Praneetvatakul
Background: Unilateral vocal fold mobility impairment (UVFMI) causes dysphonia and/or dysphagia, which can significantly affect a patient’s ability to communicate and perform regular daily life activities as well as the quality of life. Voice therapy offers a less invasive and more preferential method for patients. However, there are limitations concerning the integration of multiple therapy approaches. Voice therapy exercises with clear methodologies are required to plan and conduct therapy systematically, and frequency would be required for each exercise. Therefore, this study was conducted by applying the protocols of voice therapy in adult patients with unilateral vocal fold mobility impairment. Objective: This feasibility study is a prospective cohort, pre-post single arm, designed to determine whether the voice therapy protocol (VTP) can enhance voice quality in adult patients with unilateral vocal fold mobility impairment (UVFMI) in a pilot study. Materials and methods: All subjects received 12 sessions of voice therapy protocol, with each session conducted weekly for 45 minutes. The voice therapy protocol applied in this study consisted of vocal hygiene education, abdominal breathing exercises, vocal function exercises, pushing exercises, muscle relaxation exercises, and applied resonance voice therapy. The outcomes of protocols for voice therapy were measured before and after treatment using subjective voice assessments (GIRBAS scale) and objective voice assessments (Dr. Speech program and electroglottography-EGG). Results: Cases 2, 7, 10, 11, and 13 improved after receiving VTP. As for other participants, there are still some voice parameters that need to be monitored. Overall, it was found that the participants’ voice parameters were changing within the acceptable range, with MPT, jitter, shimmer, and HNR values significantly different (p<0.05). Conclusion: The findings of this study indicated that the voice therapy protocol was a worthwhile alternative and could be used to develop further treatment guidelines for adult patients with UVFMI at a speech clinic.
{"title":"Efficacy of the voice therapy protocol (VTP) for adult patients with unilateral vocal fold mobility impairment; a feasibility study","authors":"Jureemas Wilaklang, Kalyanee Makarabhirom, S. Thayansin, Phurich Praneetvatakul","doi":"10.12982/jams.2024.017","DOIUrl":"https://doi.org/10.12982/jams.2024.017","url":null,"abstract":"Background: Unilateral vocal fold mobility impairment (UVFMI) causes dysphonia and/or dysphagia, which can significantly affect a patient’s ability to communicate and perform regular daily life activities as well as the quality of life. Voice therapy offers a less invasive and more preferential method for patients. However, there are limitations concerning the integration of multiple therapy approaches. Voice therapy exercises with clear methodologies are required to plan and conduct therapy systematically, and frequency would be required for each exercise. Therefore, this study was conducted by applying the protocols of voice therapy in adult patients with unilateral vocal fold mobility impairment. Objective: This feasibility study is a prospective cohort, pre-post single arm, designed to determine whether the voice therapy protocol (VTP) can enhance voice quality in adult patients with unilateral vocal fold mobility impairment (UVFMI) in a pilot study. Materials and methods: All subjects received 12 sessions of voice therapy protocol, with each session conducted weekly for 45 minutes. The voice therapy protocol applied in this study consisted of vocal hygiene education, abdominal breathing exercises, vocal function exercises, pushing exercises, muscle relaxation exercises, and applied resonance voice therapy. The outcomes of protocols for voice therapy were measured before and after treatment using subjective voice assessments (GIRBAS scale) and objective voice assessments (Dr. Speech program and electroglottography-EGG). Results: Cases 2, 7, 10, 11, and 13 improved after receiving VTP. As for other participants, there are still some voice parameters that need to be monitored. Overall, it was found that the participants’ voice parameters were changing within the acceptable range, with MPT, jitter, shimmer, and HNR values significantly different (p<0.05). Conclusion: The findings of this study indicated that the voice therapy protocol was a worthwhile alternative and could be used to develop further treatment guidelines for adult patients with UVFMI at a speech clinic.","PeriodicalId":298884,"journal":{"name":"Journal of Associated Medical Sciences","volume":"53 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139112586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kanyaruck Jindaphun, Nuchjira Takheaw, Witida Laopajon, S. Pata, W. Kasinrerk
Background: Cannabis extract has a long history of being used in the treatment and prevention of several medical conditions. The utilization of cannabis extracts, whether for medical or localized purposes, is widely observed. In cannabis extract, cannabidiol (CBD) is one of the most important non-psychoactive compounds. Several studies have demonstrated that CBD has several benefits in the treatment of various medical conditions. Nevertheless, CBD has also been demonstrated to suppress both innate and adaptive immune responses. Despite CBD has claimed to have many benefits, the toxicity of CBD is often pointed out and discussed. Nonetheless, the data on the toxicity effects of CBD on immune cells are limited. Objectives: In this study, we aimed to investigate the toxicity effects of various concentrations of CBD on immune cells, including CD4 T cells, CD8 T cells, B cells, NK cells, and monocytes. Materials and methods: Various concentrations of peripheral blood mononuclear cells (PBMCs) were treated with various concentrations of CBD or relative concentrations of methanol as a diluent control for 12, 24, and 48 hrs. Cell morphology was observed using flow cytometry. The percentage of cell death in the treated cells was determined by cell viability assay. In addition, the toxic effects of CBD on PBMC sub-populations were determined by staining with fluorochromeconjugated zombie viability dye and fluorochrome-conjugated monoclonal antibodies specific to each cell sub-population. Then, the percentage of cell death in each sub-population was assessed using flow cytometry. Results: CBD at concentrations of 40 and 80 µM showed toxicity effects on PBMCs. At these concentrations, CBD induced both cell morphological changes and cell death. While 20 µM CBD induced different effects, ranging from none to mild and high toxicity. The toxicity of CBD at 20 µM concentration depends on the individual. In contrast, CBD at ten µM and below showed no toxicity to PBMCs. The observed toxic effects of CBD occurred in all sub-populations of PBMCs, including CD4 T cells, CD8 T cells, B cells, NK cells, and monocytes. Conclusion: CBD has toxicity effects on immune cells. These effects depend on CBD concentrations, PBMC concentrations, and the duration of CBD exposure. Our findings emphasize the importance of awareness for CBD users when consuming CBD.
{"title":"Toxicity effects of Cannabidiol (CBD) on immune cells","authors":"Kanyaruck Jindaphun, Nuchjira Takheaw, Witida Laopajon, S. Pata, W. Kasinrerk","doi":"10.12982/jams.2024.010","DOIUrl":"https://doi.org/10.12982/jams.2024.010","url":null,"abstract":"Background: Cannabis extract has a long history of being used in the treatment and prevention of several medical conditions. The utilization of cannabis extracts, whether for medical or localized purposes, is widely observed. In cannabis extract, cannabidiol (CBD) is one of the most important non-psychoactive compounds. Several studies have demonstrated that CBD has several benefits in the treatment of various medical conditions. Nevertheless, CBD has also been demonstrated to suppress both innate and adaptive immune responses. Despite CBD has claimed to have many benefits, the toxicity of CBD is often pointed out and discussed. Nonetheless, the data on the toxicity effects of CBD on immune cells are limited. Objectives: In this study, we aimed to investigate the toxicity effects of various concentrations of CBD on immune cells, including CD4 T cells, CD8 T cells, B cells, NK cells, and monocytes. Materials and methods: Various concentrations of peripheral blood mononuclear cells (PBMCs) were treated with various concentrations of CBD or relative concentrations of methanol as a diluent control for 12, 24, and 48 hrs. Cell morphology was observed using flow cytometry. The percentage of cell death in the treated cells was determined by cell viability assay. In addition, the toxic effects of CBD on PBMC sub-populations were determined by staining with fluorochromeconjugated zombie viability dye and fluorochrome-conjugated monoclonal antibodies specific to each cell sub-population. Then, the percentage of cell death in each sub-population was assessed using flow cytometry. Results: CBD at concentrations of 40 and 80 µM showed toxicity effects on PBMCs. At these concentrations, CBD induced both cell morphological changes and cell death. While 20 µM CBD induced different effects, ranging from none to mild and high toxicity. The toxicity of CBD at 20 µM concentration depends on the individual. In contrast, CBD at ten µM and below showed no toxicity to PBMCs. The observed toxic effects of CBD occurred in all sub-populations of PBMCs, including CD4 T cells, CD8 T cells, B cells, NK cells, and monocytes. Conclusion: CBD has toxicity effects on immune cells. These effects depend on CBD concentrations, PBMC concentrations, and the duration of CBD exposure. Our findings emphasize the importance of awareness for CBD users when consuming CBD.","PeriodicalId":298884,"journal":{"name":"Journal of Associated Medical Sciences","volume":"50 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139112621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Non-communicable diseases pose a considerable risk for the elderly population. This study aimed to investigate the impact of incorporating bitter vegetables into the diets of elderly individuals on their nutritional status. The study involved regular consumption of northern foods, such as Malidmai (Peka), salae, neem (neem), bitter gourd, and cassia, at least once a day for three months. Materials and methods: A randomized clinical trial recruited eighty individuals aged 60 years and above. One group was allowed to eat ad libitum, while the other group followed a recommended menu that emphasized bitter flavors. The study assessed dietary intake, body composition, and blood biochemical parameters. Results: The findings revealed a significant reduction in energy, saturated fat, and cholesterol intake, with the bitter group experiencing a statistically significant decrease in sugar consumption. The bitter group also demonstrated a considerable reduction in anthropometric and metabolic parameters when compared to the control group and baseline measures. These results indicate the potential benefits of bitter substances in managing or preventing obesity and type 2 diabetes in the elderly. Conclusion: Encouraging the elderly to consume at least one bitter meal per day for 12 weeks resulted in a reduction in weight gain, adipose tissue, sugar levels, and LDL-C. The study highlights the importance of incorporating bitter vegetables into the diets of elderly individuals for better nutritional status and health outcomes.
{"title":"Effects of promoting eating foods containing bitter vegetables on nutritional status in the elderly","authors":"Wittawas Sajjapong, Kamonwan Jongsomchai, Uratcha Sadjapong, Pornchai Sooksaen","doi":"10.12982/jams.2024.015","DOIUrl":"https://doi.org/10.12982/jams.2024.015","url":null,"abstract":"Background: Non-communicable diseases pose a considerable risk for the elderly population. This study aimed to investigate the impact of incorporating bitter vegetables into the diets of elderly individuals on their nutritional status. The study involved regular consumption of northern foods, such as Malidmai (Peka), salae, neem (neem), bitter gourd, and cassia, at least once a day for three months. Materials and methods: A randomized clinical trial recruited eighty individuals aged 60 years and above. One group was allowed to eat ad libitum, while the other group followed a recommended menu that emphasized bitter flavors. The study assessed dietary intake, body composition, and blood biochemical parameters. Results: The findings revealed a significant reduction in energy, saturated fat, and cholesterol intake, with the bitter group experiencing a statistically significant decrease in sugar consumption. The bitter group also demonstrated a considerable reduction in anthropometric and metabolic parameters when compared to the control group and baseline measures. These results indicate the potential benefits of bitter substances in managing or preventing obesity and type 2 diabetes in the elderly. Conclusion: Encouraging the elderly to consume at least one bitter meal per day for 12 weeks resulted in a reduction in weight gain, adipose tissue, sugar levels, and LDL-C. The study highlights the importance of incorporating bitter vegetables into the diets of elderly individuals for better nutritional status and health outcomes.","PeriodicalId":298884,"journal":{"name":"Journal of Associated Medical Sciences","volume":"53 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139112719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：